Cancer Research SABCS  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 7252-7256, November 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koutcher, J. A.
Right arrow Articles by Kim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koutcher, J. A.
Right arrow Articles by Kim, J. H.

Changes in Radiation Sensitization Induced by Fluosol-DA as Measured by 31P Nuclear Magnetic Resonance Spectroscopy1

Jason A. Koutcher2, Alan A. Alfieri, Alice B. Kornblith, Mary L. Devitt, David Cowburn, Douglas Ballon and Jae H. Kim

Departments of Medical Physics [J. A. K., A. A. A., M. L. D., D. B.], Medical Imaging [J. A. K.], Medicine [J. A. K.], and Psychiatry [A. B. K.], Memorial Sloan-Kettering Cancer Center New York, New York 10021; The Rockefeller University [D. C.] New York, New York 10021; and Department of Radiation Oncology, Henry Ford Hospital [J. H. K.], Detroit, Michigan 48202

Numerous agents have been studied in attempts to sensitize radioresistant hypoxic tumor cells. We have investigated the effect of Fluosol-DA plus carbogen (95% oxygen and 5% CO2) on the sensitivity of a radioresistant mammary carcinoma in C3H/He mice and also on tumor metabolism by 31P nuclear magnetic resonance spectroscopy. Statistically significant increases in phosphocreatine/Pi were noted for small- (150–350 mm3) and medium-(351–650 mm3) sized tumors treated with Fluosol-DA plus carbogen. Small tumors were shown to undergo significant radiosensitization in the presence of Fluosol-DA plus carbogen and medium-sized tumors showed a lesser degree of radiosensitization. Large tumors (>900 mm3) showed no effect. Fluosol-DA or carbogen alone had no effects on animals with any tumor volume, as monitored by significant changes in radiosensitivity or nuclear magnetic resonance parameters. An approximately linear relationship was found between the decrease in the values for radiation dose which yields 50% tumor control and the increase in phosphocreatine/Pi, with a correlation of r = -0.93. 31P nuclear magnetic resonance spectroscopy may be useful for monitoring changes in radiosensitivity induced by agents which alter tumor oxygenation and subsequent metabolic status.

1 This work was supported by National Cancer Institute Grant R29 CA 43841 and funds from the Whitaker Foundation.

2 To whom requests for reprints should be addressed, at Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

Received 4/30/90. Accepted 8/20/90.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. P. Dyke, K. L. Zakian, W. M. Spees, C. Matei, Y. Chen, X. Mao, D. C. Shungu, and J. A. Koutcher
Metabolic Response of the CWR22 Prostate Tumor Xenograft after 20 Gy of Radiation Studied by 1H Spectroscopic Imaging
Clin. Cancer Res., October 1, 2003; 9(12): 4529 - 4536.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. U. Nielsen, P. Daugaard, L. Bentzen, H. Stodkilde-Jorgensen, J. Overgaard, M. R. Horsman, and R. J. Maxwell
Effect of Changing Tumor Oxygenation on Glycolytic Metabolism in a Murine C3H Mammary Carcinoma Assessed by in Vivo Nuclear Magnetic Resonance Spectroscopy
Cancer Res., July 1, 2001; 61(13): 5318 - 5325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.